BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Major histocompatibility complex class II (MHCII)

May 21, 2015 7:00 AM UTC

Mouse studies suggest up-regulating MHCII-expressing group 3 innate lymphoid cells (ILC3s) in the intestines could help treat IBD. MHCII expression on ILC3s was lower in the intestinal tissue of pedia...